Entering text into the input field will update the search result below

GW Pharmaceuticals reports FQ3 results

  • GW Pharmaceuticals (NASDAQ:GWPH +0.6%) FQ3 results (₤): Revenues: 2.3M (-73.3%); R&D Expense: 25.6M (+23.1%); SG&A: 5.6M (+86.7%); Operating Loss: (18.4M) (+25.8%); Net Loss: (12.2M) (+43.0%); Loss Per Share: (0.05) (+44.4%); Quick Assets: 191.2M (-18.6%); CF Ops: (57.2M) (-137.3%).
  • No guidance given.

Recommended For You

Related Stocks

SymbolLast Price% Chg
GWPH--
GW Pharmaceuticals plc